This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
09/04/15 - 3:59:59 PM ET (BATS BZX Real-time Price)
Div Yield: --
AMRI Day's Range
AMRI 52 Week Range
AMRI Business Summary
Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia.View AMRI key stats
Albany Molecular Research Inc - AMRI - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Albany Molecular Research Inc as a
Hold with a ratings score of C.
Report Snippet: We rate ALBANY MOLECULAR RESH INC (AMRI) a HOLD. The primary factors that have impacted our rating are mixed – some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins.